INMED PHARMACEUTICALS INC's ticker is INM and the CUSIP is 457637502. A total of 22 filers reported holding INMED PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $0 | -100.0% | 545 | 0.0% | 0.00% | -100.0% |
Q1 2022 | $1,000 | 0.0% | 545 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $1,000 | 0.0% | 545 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $1,000 | -50.0% | 545 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $2,000 | 0.0% | 545 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $2,000 | 0.0% | 545 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $2,000 | – | 545 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 235,000 | $776,000 | 0.02% |
Hudson Bay Capital Management LP | 161,000 | $531,000 | 0.01% |
AllSquare Wealth Management LLC | 545 | $2,000 | 0.00% |
Creative Planning | 10,990 | $36,000 | 0.00% |
ROYAL BANK OF CANADA | 586 | $2,000 | 0.00% |
TCI Wealth Advisors, Inc. | 125 | $0 | 0.00% |
UBS Group AG | 793 | $3,000 | 0.00% |
OSAIC HOLDINGS, INC. | 936 | $4,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 16,120 | $53,000 | 0.00% |
PNC FINANCIAL SERVICES GROUP, INC. | 1,820 | $6,000 | 0.00% |